Sun Pharmaceutical Industries, an international, integrated, speciality pharmaceutical company, reported consolidated net profit of Rs 13.91 billion for the quarter ended Jun. 30, 2014 as compared to net loss of Rs 12.76 billion in the same period last year.
Total consolidated income has increased by 12.36% to Rs 39.36 billion for the quarter ended Jun. 30, 2014 from Rs 35.03 billion in the year ago period.
Shares of the company gained Rs 11.9, or 1.52%, to trade at Rs 795.80. The total volume of shares traded was 79,709 at the BSE (9.33 a.m., Wednesday).